The New Serum-Free OptiPASS® Medium in Cold and Oxygen-Free Conditions: An Innovative Conservation Method for the Preservation of MDA-MB-231 Triple Negative Breast Cancer Spheroids
Authors:
- Antoine GoisnardAGAntoine Goisnard
- Clémence DuboisCDClémence Dubois
- Pierre DaumarPDPierre Daumar
- Corinne AubelCACorinne Aubel
- Marie DepresleMDMarie Depresle
- Jean GauthierJGJean Gauthier
- Bernard VidalincBVBernard Vidalinc
- Frédérique Penault-LlorcaFPFrédérique Penault-Llorca
- Emmanuelle MounetouEMEmmanuelle Mounetou
- Mahchid BamdadMBMahchid Bamdad
Open Access
Abstract
Cancer spheroids are very effective preclinical models to improve anticancer drug screening. In order to optimize and extend the use of spheroid models, these works were focused on the development of a new storage concept to maintain these models in the longer term using the Triple-Negative Breast Cancer MDA-MB-231 spheroid models. The results highlight that the combination of a temperature of 4 °C and oxygen-free conditions allowed the spheroid characteristics of OptiPASS® serum-free culture medium to preserve the spheroid characteristics during 3-, 5- or 7-day-long storage. Indeed, after storage they were returned to normal culture conditions, with recovered spheroids presenting similar growth rates (recovery = 96.2%), viability (Live/Dead® profiles) and metabolic activities (recovery = 90.4%) compared to nonstored control spheroids. Likewise, both recovered spheroids (after storage) and nonstored controls presented the same response profiles as two conventional drugs, i.e., epirubicin and cisplatin, and two anti-PARP1 targeted drugs—i.e., olaparib and veliparib. This new original storage concept seems to induce a temporary stop in spheroid growth while maintaining their principal characteristics for further use. In this way, this innovative and simple storage concept may instigate future biological sample preservation strategies.Keywords
This publication has 43 references indexed in Scilit:
- Mechanisms of disseminated cancer cell dormancy: an awakening fieldNature Reviews Cancer, 2014
- Phase II and Phase III attrition rates 2011–2012Nature Reviews Drug Discovery, 2013
- The multicellular tumor spheroid model for high-throughput cancer drug discoveryExpert Opinion on Drug Discovery, 2012
- Evaluation of Bone Marrow-Derived Mesenchymal Stem Cells After Cryopreservation and Hypothermic Storage in Clinically Safe MediumTissue Engineering Part C: Methods, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Immunohistochemical Expression of Stem Cell, Endothelial Cell, and Chemosensitivity Markers in Primary Glioma Spheroids Cultured in Serum-Containing and Serum-Free MediumNeurosurgery, 2010
- A comparative study of freezing single cells and spheroids: Towards a new model system for optimizing freezing protocols for cryobanking of human tumoursCryobiology, 2009
- Modeling Tissue Morphogenesis and Cancer in 3DCell, 2007
- Extended storage of red blood cells under anaerobic conditionsVox Sanguinis, 2006
- Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymeraseNature, 2005